Abstract: Systems and method for upgrading pyrolysis oil to produce greater value aromatic compounds includes combining heavy pyrolysis oil and a diluent to produce the pyrolysis oil feed withleast 30 wt. % multi-ring aromatic compounds boiling at greater than 360° C. The systems and methods include passing the pyrolysis oil feed to a fixed bed reactor having a hydrocracking catalyst that includes pellets having a particle size greater than or equal to 0.1 millimeter. The hydrocracking catalyst is a mixed metal oxide catalyst that includes a binder and mixed metal oxide particles or a supported metal oxide catalyst that includes molybdenum oxide and nickel oxide supported on a catalyst support material comprising a large-pore alumina. The methods may further include contacting the pyrolysis oil feed with the hydrogen in the presence of the hydrocracking catalyst at reaction conditions in the fixed bed reactor to produce a reaction effluent.

Abstract: A method for upgrading pyrolysis oil includes contacting a pyrolysis oil feed with hydrogen in the presence of a mixed metal oxide catalyst in a first fixed-bed reactor, where: the pyrolysis oil feed comprises multi-ring aromatic compounds comprising greater than or equal to sixteen carbon atoms, and contacting the pyrolysis oil feed with hydrogen in the presence of the mixed metal oxide catalyst in the first fixed-bed reactor to convert at least a portion of the multi-ring aromatic compounds in the pyrolysis oil feed to di-aromatic compounds, tri-aromatic compounds, or both, passing an intermediate stream comprising the di-aromatic compounds, tri-aromatic compounds, or both to a second fixed-bed reactor downstream of the first fixed-bed reactor; and contacting the intermediate stream with hydrogen in the presence of a mesoporous supported metal catalyst in a second fixed-bed reactor.

Abstract: The embodiments of the present disclosure may provide an oncolytic virus vector and an application thereof. The oncolytic virus vector may comprise a recombinant nucleic acid. The recombinant nucleic acid may include: (i) a first nucleic acid fragment encoding a soluble PD-1 molecule; (ii) a second nucleic acid fragment encoding a CD86 molecule; and (iii) a third nucleic acid fragment encoding an antibody to a CD3 molecule.

Abstract: The embodiments of the present disclosure may provide an oncolytic virus vector and an application thereof. The oncolytic virus vector may comprise a recombinant nucleic acid. The recombinant nucleic acid may include: (i) a first nucleic acid fragment encoding a soluble PD-1 molecule; (ii) a second nucleic acid fragment encoding a CD86 molecule; and (iii) a third nucleic acid fragment encoding an antibody to a CD3 molecule.

Abstract: This invention provides a method for inducing cell senescence by recombinant interferon with altered spatial configuration, wherein the interferon is encoded by a nucleotide sequence having the sequence of SEQ ID NO.2.